CN106749133A - A kind of method for preparing Ta Simeiqiong - Google Patents

A kind of method for preparing Ta Simeiqiong Download PDF

Info

Publication number
CN106749133A
CN106749133A CN201510814397.2A CN201510814397A CN106749133A CN 106749133 A CN106749133 A CN 106749133A CN 201510814397 A CN201510814397 A CN 201510814397A CN 106749133 A CN106749133 A CN 106749133A
Authority
CN
China
Prior art keywords
bases
dihydrobenzofuranes
reaction
simeiqiong
solvent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510814397.2A
Other languages
Chinese (zh)
Other versions
CN106749133B (en
Inventor
李喜安
朱建荣
钟宏班
付长安
岳李荣
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Jingxin Pharmaceutical Co Ltd
Original Assignee
Zhejiang Jingxin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Jingxin Pharmaceutical Co Ltd filed Critical Zhejiang Jingxin Pharmaceutical Co Ltd
Priority to CN201510814397.2A priority Critical patent/CN106749133B/en
Publication of CN106749133A publication Critical patent/CN106749133A/en
Application granted granted Critical
Publication of CN106749133B publication Critical patent/CN106749133B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention provides a kind of preparation method of Ta Simeiqiong; the method is with (S) -4- (oxirane -2- bases) -2; 3- Dihydrobenzofuranes are initiation material; (1R is generated through cyanalation reaction; 2R) -2- (2; 3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third, reduction generation ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine and acylation reaction is obtained Ta Simeiqiong again.The inventive method reactions steps are few, simple to operate, and post processing is easy, and product yield is high, and cost of material is low, is conducive to industrialized production, there is larger application value.

Description

A kind of method for preparing Ta Simeiqiong
Technical field
The present invention relates to pharmaceutical chemistry, and in particular to prepared by the preparation of medicine, more particularly to one kind The method of Ta Simeiqiong.
Background technology
Ta Simeiqiong, trade name Hetlioz, chemical entitled 1R-trans)-N- [[2- (2,3- Dihydro -4- benzofuranyls) cyclopropyl] methyl] propionamide, shown in structural formula I.The medicine is by U.S. Maryland State Vanda drugmakers of state develop, the FDA of on January 31st, 2014 approval listings, It is a kind of new melatonin (melatonin) receptor stimulating agent, is lost completely for treating Non- 24- hours sleep arousal disorders (" non-24 ") in bright patient.During " non-24 " is blind person A kind of length of one's sleep puzzlement that chronic disorders of circadian rhythms causes, light does not enter their eye Eyeball and its biological clock and 24- hour light and shade cycle synchronisation can not be made, i.e. patient possibility Sleep is had difficulty in going to sleep or keeps, some patient sleeps' patterns are reversed, need to slept and evening on daytime It is clear-headed.
At present, the synthetic method about Ta Simeiqiong is substantially by preparing with chiral cylopropyl With key intermediate (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) first of ring third of amino Amine II, then intermediate II carry out amidatioon and obtain Ta Simeiqiong.
Patent US5856529 is reported, with (E) -3- (2,3- Dihydrobenzofuranes -4- bases) propylene Acid is initiation material, with the condensation of (-) -2,10- camphorsulfonic acids lactams, is entered with diazomethane Row is Cyclopropanated to obtain chiral cylopropyl intermediate, is reduced with lithium aluminium hydride reduction, then pass through SWERN (polite oxidation reaction) oxidations obtain aldehyde, are then condensed into oxime with hydroxylamine hydrochloride, enter One step is reduced into amine, and the reaction of last and propionyl chloride obtains Ta Simeiqiong.But the method reaction step It is rapid more long, and chiral intermediate must be built with diazomethane, it is unfavorable for that safe is operated, it is difficult To industrialize, specific reactions steps are as follows:
The preparation method of CN102675268 reports:By (1R, 2R) -2- (2,3- dihydrobenzos Furans -4- bases) cyclopropanecarboxylic acid obtains (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- through chlorination Base) formyl chloride of ring third, generate (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) through ammonolysis Ring propyl formamide, most obtains (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- through reduction afterwards Base) methylamine of ring third this key intermediate.But the initiation material acid chiral cylopropyl of the method Preparing also will be using reagents such as diazomethanes.
Reactions steps are as follows:
Patent US6214869 reports synthesizing cis 2- (2,3- Dihydrobenzofuranes -4- bases) The method of the methylamine of ring third, the method is by (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) Cyclopropyl-carbinol is initiation material, and hydroxyl is protected with mesyl, then the mesyl after protection With sodium azide effect by azide substitution, last hydrogenated aluminium lithium reduces to obtain cis 2- (2,3- Dihydrobenzofuranes -4- bases) methylamine of ring third.But the technological requirement of the method is harsh, uses height Danger reagent N aN3, it is unfavorable for industrialized production.
Reactions steps are as follows:
In a word, the method for prior art report all presence use highly difficult, expensive reagent, work Skill complex operation, equipment requirement defect high, it is impossible to be suitable to industrial production, needs improvement badly.
The content of the invention
The technical problems to be solved by the invention are to overcome above-mentioned weak point, and research and design is anti- Should be simple, easy to operate, low cost, the method for preparing Ta Simeiqiong of high income.
The invention provides a kind of method for preparing Ta Simeiqiong, with shown in following reaction equation:
The method of the present invention is comprised the following steps:
(1) (S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes and cyanylation agent are in alkali In the presence of, cyanalation reaction generation (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) The third formonitrile HCN of ring III:
Cyanylation agent described in the step is in cyanogen methyl phosphorodithioate or cyanogen methyl quaternary phosphonium salt One or more, preferably cyanogen methyl phosphorodithioate, most preferably cyanogen methyl acid phosphate diethylester; (S) mol ratio of -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes and cyanylation agent It is 1:1~5, wherein it is preferred that 1:1~3;
The alkali is selected from sodium hydride, sodium tert-butoxide, potassium tert-butoxide, sodium methoxide or caustic alcohol One or more, preferably sodium hydride;(S) -4- (oxirane -2- bases) -2,3- dihydrobenzos Furans is 1 with the mol ratio of alkali:1~5, preferably 1:1~3.
Reaction dissolvent is selected from one or more in toluene, paraxylene, n-hexane or hexamethylene, It is preferred that hexamethylene;The consumption of solvent is (S) -4- (oxirane -2- bases) -2,3- dihydrobenzos 8~50 times of furans quality, preferably 25~30 times.
Reaction temperature is 50~110 DEG C, preferably 70~100 DEG C;Reaction time is 4~12 hours, It is preferred that 8~10 hours.
Post-reaction treatment:0.5-2 times of reactant solubilization dosage of water quenching is gone out reaction, then Extracted 3 times through the ethyl acetate of each be quantity of solvent 0.5-2 times successively, use equivalent water again Extraction, merges organic pressure of subtracting each other and is evaporated (40 DEG C, 0.01MPa rotary evaporations), through column chromatography (post Type silicagel column 25*500mm glass silica gel posts, silica gel 200-300 mesh, eluting solvent methyl alcohol: Dichloromethane=1:10) active ingredient is collected, thin layer detection terminal obtains target product III.
(2) (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third is reduced with reducing agent Reaction generation ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine II:
Reducing agent described in the step is metal hydride, and preferred metal hydride is aluminum hydride Lithium;(1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third rubs with reducing agent You are than being 1:1~5, preferably 1:1~3.
Reduction reaction described in the step with metal hydride reducing agent except that can also add road Lewis acid catalysed promoted is reacted, and described lewis acid is selected from BF3、SnCl4、FeCl3、AlCl3、 ZnCl2Or CuCl2, preferably BF3Or ZnCl2
Reaction dissolvent be selected from tetrahydrofuran, 2- methyltetrahydrofurans, ether, methyl tertiary butyl ether(MTBE), One or more in isopropyl ether, glycol dimethyl ether or dioxane, preferably tetrahydrofuran or Methyltetrahydrofuran;The consumption of solvent is (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- Base) 8~60 times, preferably 20~30 times of ring the third formonitrile HCN quality.
Reaction temperature is -50~100 DEG C, and preferably 20~30 DEG C, the reaction time is 0.5~12 hour, It is preferred that 8~10 hours.
Post-reaction treatment:To the saturated sodium bicarbonate of 0.5-2 times that quantity of solvent is added in reactant The aqueous solution is quenched, suction filtration, filter cake with being every time the 0.1-1 times of methanol rinse 3 times of quantity of solvent, Filtrate decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporations), through column chromatography (column type 25*500mm, Eluting solvent methyl alcohol:Dichloromethane=1:10) active ingredient is collected, thin layer detection terminal obtains mesh Mark thing II.
(3) ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine and acylation Reagent, in the presence of acid binding agent, carries out acylation reaction generation Ta Simeiqiong:
The reaction of the step is that solvent-free or carry out under having solvent, the solvent is selected from dichloromethane One or more in alkane, chloroform, 1,2- dichloroethanes, n-hexane, hexamethylene or methyl alcohol, It is preferred that dichloromethane;The consumption of solvent is ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- Base) cyclopropyl) 0~50 times, preferably 5~15 times of methylamine quality.
The acylting agent is selected from one or more in propionyl chloride, propionic acid or propionic ester, excellent Select propionyl chloride;((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) first Amine is 1 with the mol ratio of acylting agent:1~10, preferably 1:1~3.
The acid binding agent is triethylamine, diisopropyl ethyl amine, sodium acid carbonate, sodium carbonate, carbon One or more in sour potassium or pyridine, preferably triethylamine;((1R, the 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) mol ratio of methylamine and acid binding agent is 1:1~8, preferably 1:1~3.
Reaction temperature is -20~80 DEG C, preferably 0~20 DEG C;Reaction time is 0.5~12 hour, It is preferred that 6~10 hours.
Post-reaction treatment:Reactant decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporations) solvent, Column chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10) collect effectively into Point, thin layer detection terminal obtains target product I.
It is a further object of the present invention to provide compound (1R, 2R) -2- (2,3- dihydrobenzos Furans -4- bases) the third formonitrile HCN of ring III, the compound is represented with following formula:
Prepared by following method:
(S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes exist with cyanylation agent in alkali Under, cyanalation reaction generation (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) first of ring third Nitrile III:
Described cyanylation agent be one kind in cyanogen methyl phosphorodithioate or cyanogen methyl quaternary phosphonium salt or It is various, preferably cyanogen methyl phosphorodithioate, most preferably cyanogen methyl acid phosphate diethylester;(S) -4- (epoxies Ethane -2- bases) mol ratio of -2,3- Dihydrobenzofuranes and cyanylation agent is 1:1~5, its In preferably 1:1~3;
The alkali is selected from sodium hydride, sodium tert-butoxide, potassium tert-butoxide, sodium methoxide or caustic alcohol One or more, preferably sodium hydride;(S) -4- (oxirane -2- bases) -2,3- dihydrobenzos Furans is 1 with the mol ratio of alkali:1~5, preferably 1:1~3.
Reaction dissolvent is selected from one or more in toluene, paraxylene, n-hexane or hexamethylene, It is preferred that hexamethylene;The consumption of solvent is (S) -4- (oxirane -2- bases) -2,3- dihydrobenzos 8~50 times of furans quality, preferably 25~30 times.
Reaction temperature is 50~110 DEG C, preferably 70~100 DEG C;Reaction time is 4~12 hours, It is preferred that 8~10 hours.
Post-reaction treatment:0.5-2 times of reactant solubilization dosage of water quenching is gone out reaction, then Extracted 3 times through the ethyl acetate of each be quantity of solvent 0.5-2 times successively, use equivalent water again Extraction, merges organic pressure of subtracting each other and is evaporated (40 DEG C, 0.01MPa rotary evaporations), through column chromatography (post Type silicagel column 25*500mm glass silica gel posts, silica gel 200-300 mesh, eluting solvent methyl alcohol: Dichloromethane=1:10) active ingredient is collected, thin layer detection terminal obtains target product III.
Compound (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) third formonitrile HCN of ring III Ta Simeiqiong can be prepared by reduction, therefore is the key intermediate of the inventive method.
The inventive method reactions steps are few, simple to operate, and post processing is easy, and product yield is high, Cost of material is low, is conducive to industrialized production, there is larger application value.
Specific embodiment
Raw material and reagent used by following examples are commercially available.
(S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes for commercially available or
Embodiment 1 prepares Ta Simeiqiong
(1) preparation of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) third formonitrile HCN of ring III
By sodium hydride (3.9g, 2.0equiv., 98.6mmol) add 80mL hexamethylenes in, Cyanogen methyl acid phosphate diethylester (9.6g, 1.1 equiv (equivalent), 54.2mmol) is slowly added dropwise, Completion of dropping, is warmed up to 70 DEG C, then (S) -4- (epoxies for being slowly added dropwise the dissolving of 80mL hexamethylenes Ethane -2- bases) -2,3- Dihydrobenzofuranes (8.0g, 1.0equiv., 49.3mmol), drop Add complete, be warmed up to 80 DEG C, after reaction 8 hours, the 50ml that adds water is quenched reaction, Ran Houyi It is secondary through ethyl acetate 100ml*3, water 100ml extract, merge it is organic subtract each other pressure be evaporated (40 DEG C, 0.01MPa rotary evaporations), through column chromatography (column type silicagel column 25*500mm glass silica gel posts, Silica gel 200-300 mesh, eluting solvent methyl alcohol:Dichloromethane=1:10) active ingredient is collected, it is thin Layer detection terminal obtains the oil of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) third formonitrile HCN of ring III Shape thing 7.8g, yield 86%.
Confirmation is object III after testing.
1HNMR(CDCl3) δ 7.08 (t, J=8.0Hz, 1H), 6.73 (d, J=8.0Hz, 1H), 6.40 (d, J=8.0Hz, 1H), 4.66 (t, J=8.0Hz, 2H), 3.33-3.29(m,2H),2.58-2.53(m,1H),1.66-1.62(m,1H), 1.59-1.54(m,1H),1.51-1.50(m,1H).13CNMR(CDCl3)δ160.13, 134.20,128.61,126.99,121.06,116.09,108.53,71.16,28.52, 22.86,14.46,5.58.MS(ESI):M/z=285.2,280.0 (M+Na+)。
(2) prepared by ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine II By (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third (3g, 1.0 equivalents, 16.2mmol) it is dissolved in 120mL2- methyltetrahydrofurans, after bath cooling on the rocks, (0-5 DEG C) Lithium aluminium hydride reduction (0.92g, 1.5equiv., 24.3mmol) is dividedly in some parts, it is after 3 hours plus full It is quenched with sodium bicarbonate aqueous solution 100ml, suction filtration, filter cake methanol rinse 3 times is (every time 10ml), filtrate decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporations), through column chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10) active ingredient, thin layer detection are collected Terminal obtains 2.95g objects, yield 96%;
(3) N- (((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methyl) propionyl It is prepared by amine (Ta Simeiqiong) I
((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine (2.48g, 1.0 Equiv., 13.1mmol) it is dissolved in 30mL dichloromethane, bath cooling 0-5OC on the rocks is used Syringe adds propionyl chloride (1.33g/1.3mL, 1.1equiv., 14.4mmol), has at once white Color solid is produced, and triethylamine (1.32g/1.8mL, 1.0equiv., 13.1mmol) is then added dropwise, System becomes clarification immediately, after half an hour, removes ice bath, and (20-25 DEG C) of room temperature is reacted overnight, Reactant decompression is spin-dried for (40 DEG C, 0.01MPa rotary evaporations) solvent, column chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10) active ingredient, thin layer detection are collected Terminal get Ta Simeiqiong product 2.8g, yield 88%.
Confirmation obtains product for Ta Simeiqiong after testing.
MS[M+H]:246.1
Embodiment 2 prepares Ta Simeiqiong
(1) preparation of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) third formonitrile HCN of ring III
By potassium tert-butoxide (16.6g, 2.0equiv., 147.9mmol) add 200mL toluene in, It is slowly added dropwise cyanogen methyl acid phosphate diethylester (26.2g, 3 equivalents, 147.9mmol), completion of dropping, It is warmed up to 100 DEG C, then (S) -4- (oxirane -2- for being slowly added dropwise the dissolving of 100mL toluene Base) -2,3- Dihydrobenzofuranes (8.0g, 1.0 equivalents, 49.3mmol), completion of dropping, After maintaining 100 DEG C of reactions 10 hours, plus 50ml water quenchings are gone out reaction, then through extraction acetic acid second Ester 100*3ml and water 100ml, organic phase evaporated under reduced pressure (40 DEG C, 0.01MPa rotary evaporations), Through column chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10) collect effective Composition, thin layer detection terminal obtains grease 9.0g, yield 88%.
(2) prepared by ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine II By (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third (3g, 1.0 equivalents 6.2mmol) it is dissolved in 100mL isopropanols, after 0-5 DEG C of cooling of bath on the rocks, is dividedly in some parts hydrogenation Aluminium lithium (1.85g, 3 equivalents, 48.6mmol), after 3 hours, plus saturated sodium bicarbonate is quenched, Suction filtration, filter cake 10ml isopropyl alcohols 3 times, filtrate decompression is spin-dried for (40 DEG C, 0.01MPa Rotary evaporation), through column chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10 Active ingredient is collected, thin layer detection terminal obtains III 2.98g, yield 97%;
(3) N- (((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methyl) propionyl It is prepared by amine (Ta Simeiqiong) I
((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine (2.48g, 1.0 Equiv., 13.1mmol) it is dissolved in 50mL n-hexanes, (0-5 DEG C) cooling of bath on the rocks is used Syringe adds propionyl chloride (1.33g/1.3mL, 1.1 equivalents, 14.4mmol), there is white at once Solid is produced, and is subsequently adding potassium carbonate (1.8g, 1.0 equivalents, 13.1mmol), and system is immediately Become clarification, after half an hour, remove ice bath, (20-25 DEG C) of room temperature is reacted overnight, decompression (40 DEG C, 0.01MPa rotary evaporations) it is spin-dried for solvent, column chromatography (column type 25*500mm, eluting solvent methyl alcohol: Dichloromethane=1:10) active ingredient is collected, thin layer detection terminal obtains product Ta Simeiqiong 2.9g, Yield 90%.
Confirmation obtains product for Ta Simeiqiong after testing.
Embodiment 3 prepares (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) third formonitrile HCN of ring III
By sodium hydride (3.9g, 2.0 equivalents, 98.6mmol) add 100mL n-hexanes in, It is slowly added dropwise cyanogen methyl acid phosphate diethylester (8.72g, 1 equivalent, 49.3mmol), completion of dropping, Temperature rising reflux, then it is slowly added dropwise (S) -4- (oxirane -2- of 100mL n-hexane dissolutions Base) -2,3- Dihydrobenzofuranes (8.0g, 1.0 equivalents, 49.3mmol), completion of dropping, After back flow reaction 4 hours, plus 50ml water quenchings are gone out reaction, then through extracting (ethyl acetate successively 100*3ml;Water 100ml), organic phase evaporated under reduced pressure (40 DEG C, 0.01MPa rotary evaporations), Through column chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10) collect effective Composition, thin layer detection terminal, obtains the 7.7g of grease III, yield 85%.
It is III that confirmation obtains product after testing.
Embodiment 4 is prepared ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) Methylamine II
By (1R, 2R) -2- obtained in embodiment 3 (2,3- Dihydrobenzofuranes -4- bases) ring third Formonitrile HCN (3g, 1.0 equivalents, 16.2mmol) is dissolved in 120mL tetrahydrofurans, at room temperature in batches Lithium aluminium hydride reduction (0.92g, 1.5 equivalents, 24.3mmol) is added, after 3 hours, plus saturated carbon Sour hydrogen sodium is quenched, suction filtration, and filter cake is rinsed 3 times with 10ml tetrahydrofurans respectively, and filtrate subtracts Pressure is spin-dried for (at 40 DEG C, 0.01MPa rotary evaporations), (column type 25*500mm, is washed through column chromatography Desolventizing methyl alcohol:Dichloromethane=1:10) active ingredient is collected, thin layer detection terminal obtains II 2.85g, yield 93%.
It is II that confirmation obtains product after testing.
Embodiment 5 prepares ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) first Amine II
By (1R, 2R) -2- obtained in embodiment 3 (2,3- Dihydrobenzofuranes -4- bases) ring third Formonitrile HCN (3g, 1.0 equivalents, 16.2mmol) is dissolved in 120mL tetrahydrofurans, at room temperature in batches (0.22g, 0.1 works as to add lithium aluminium hydride reduction (0.92g, 1.5 equivalents, 24.3mmol) and zinc chloride Amount, 1.62mmol), after 2 hours, plus saturated sodium bicarbonate is quenched, and suction filtration, filter cake uses four Hydrogen furans is rinsed 3 times, and filtrate decompression is spin-dried for (at 40 DEG C, 0.01MPa rotary evaporations), through post Chromatography (column type 25*500mm, eluting solvent methyl alcohol:Dichloromethane=1:10) active ingredient is collected, Thin layer detects terminal, obtains II 2.91g, yield 95%;
It is II that confirmation obtains product after testing.
Embodiment 6
N- (((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methyl) propionamide It is prepared by (Ta Simeiqiong) I
((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) obtained in embodiment 5 Methylamine (2.48g, 1.0equiv., 13.1mmol) is dissolved in 1, the 2- dichloroethanes of 30mL, With syringe add propionic acid (2.9g, 3equiv., 39.3mmol), back flow reaction 10 hours, Depressurize and be spin-dried for solvent (40 DEG C, 0.01MPa rotary evaporations), column chromatography (column type 25*500mm, Eluting solvent methyl alcohol:Dichloromethane=1:10) active ingredient is collected, thin layer detection terminal must be produced Thing Ta Simeiqiong 2.2g, yield 71%.
Confirmation is Ta Simeiqiong after testing.

Claims (10)

1. a kind of method for preparing Ta Simeiqiong, it is characterised in that the method reaction equation:
Comprise the following steps:
(1) (S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes and cyanylation agent are in alkali In the presence of, reaction generation (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third Ⅲ:
(2) (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third is reduced with reducing agent Generation ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine II:
(3) ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine and acylation Reagent, reacts generation Ta Simeiqiong I in the presence of acid binding agent:
2. the method for preparing Ta Simeiqiong according to claim 1, it is characterised in that Step (1) the cyanalation reagent for using that reacts is cyanogen methyl phosphorodithioate or cyanogen methyl season phosphine One or more in salt;(S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes with The mol ratio of cyanylation agent is 1:1~5;The alkali is selected from sodium hydride, sodium tert-butoxide, tertiary fourth One or more in potassium alcoholate, sodium methoxide or caustic alcohol;(S) -4- (oxirane -2- bases) -2, 3- Dihydrobenzofuranes are 1 with the mol ratio of alkali:1~5;
Reaction dissolvent is selected from one or more in toluene, paraxylene, n-hexane or hexamethylene; The consumption of solvent is (S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes quality 8~50 times;
Reaction temperature is 50~110 DEG C;Reaction time is 4~12 hours.
3. the method for preparing Ta Simeiqiong according to claim 2, it is characterised in that The reagent that cyanalation reaction described in step (1) is used is cyanogen methyl phosphorodithioate, most preferably cyanogen Methyl acid phosphate diethylester;(S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes and cyanogen The mol ratio of base reagent is 1:1~3;
The alkali is sodium hydride;(S) -4- (oxirane -2- bases) -2,3- Dihydrobenzofuranes It is 1 with the mol ratio of alkali:1~3;
Reaction dissolvent is hexamethylene;The consumption of solvent is (S) -4- (oxirane -2- bases) -2, 25~30 times of 3- Dihydrobenzofuranes quality;
Reaction temperature is 70~100 DEG C;Reaction time is 8~10 hours.
4. the method for preparing Ta Simeiqiong according to claim 1, it is characterised in that Step (2) described reducing agent is metal hydride, and preferred metal hydride is lithium aluminium hydride reduction; The mol ratio of (1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) formonitrile HCNs of ring third and reducing agent It is 1:1~5;
Reaction dissolvent be selected from tetrahydrofuran, 2- methyltetrahydrofurans, ether, methyl tertiary butyl ether(MTBE), One or more in isopropyl ether, glycol dimethyl ether or dioxane;The consumption of solvent for (1R, 2R) 8~60 times of -2- (2,3- Dihydrobenzofuranes -4- bases) ring the third formonitrile HCN quality;
Reaction temperature is -50~100 DEG C;Reaction time is 0.5~12 hour.
5. the method for preparing Ta Simeiqiong according to claim 4, it is characterised in that Step (2) described reducing agent is that metal hydride is lithium aluminium hydride reduction;(1R,2R)-2-(2,3- Dihydrobenzofuranes -4- bases) mol ratio of the formonitrile HCN of ring third and reducing agent is 1:1~3;
Reaction dissolvent is selected from tetrahydrofuran or methyltetrahydrofuran;The consumption of solvent for (1R, 2R) 20~30 times of -2- (2,3- Dihydrobenzofuranes -4- bases) ring the third formonitrile HCN quality.
6. the method for preparing Ta Simeiqiong according to claim 3 or 4, its feature exists In the reduction reaction of step (2) is except with metal hydride reducing agent, being additionally added Louis Acid catalysis promotes reaction, and described lewis acid is selected from BF3、SnCl4、FeCl3、AlCl3、 ZnCl2Or CuCl2, preferably BF3Or ZnCl2
7. the method for preparing Ta Simeiqiong according to claim 6, it is characterised in that The reduction reaction of step (2) is except with metal hydride reducing agent, being additionally added lewis acid and urging Change and promote reaction, described lewis acid is selected from BF3Or ZnCl2
8. the method for preparing Ta Simeiqiong according to claim 1, it is characterised in that Solvent-free or carry out under having solvent, the solvent is selected from two to the acylation reaction of step (3) One kind in chloromethanes, chloroform, 1,2- dichloroethanes, n-hexane, hexamethylene or methyl alcohol or It is various;The consumption of solvent is ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) 0~50 times of methylamine quality;
The acylting agent is selected from one or more in propionyl chloride, propionic acid or propionic ester;Institute State ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) methylamine and be acylated examination The mol ratio of agent is 1:1~10;
The acid binding agent be selected from triethylamine, diisopropyl ethyl amine, sodium acid carbonate, sodium carbonate, One or more in potassium carbonate or pyridine;((1R, 2R) -2- (2,3- dihydrobenzo furans Mutter -4- bases) cyclopropyl) methylamine and the mol ratio of acid binding agent be 1:1~8;
Reaction temperature is -20~80 DEG C;Reaction time is 0.5~12 hour.
9. the method for preparing Ta Simeiqiong according to claim 8, it is characterised in that Solvent described in acylation reaction described in step (3) is dichloromethane;The consumption of solvent for ((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- bases) cyclopropyl) 5~15 times of methylamine quality.;
The acylting agent is propionyl chloride;((1R, 2R) -2- (2,3- dihydrobenzo furans Mutter -4- bases) cyclopropyl) methylamine and the mol ratio of acylting agent be 1:1~3.
The acid binding agent is triethylamine;((1R, 2R) -2- (2,3- Dihydrobenzofuranes -4- Base) cyclopropyl) mol ratio of methylamine and acid binding agent is 1:1~3.
Reaction temperature is 0~20 DEG C;Reaction time is 6~10 hours.
10. compound (1R, 2R) -2- (2, the 3- Dihydrobenzofuranes -4- bases) formonitrile HCN of ring third, Characterized in that, the compound is represented with following formula:
CN201510814397.2A 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong Active CN106749133B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510814397.2A CN106749133B (en) 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510814397.2A CN106749133B (en) 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong

Publications (2)

Publication Number Publication Date
CN106749133A true CN106749133A (en) 2017-05-31
CN106749133B CN106749133B (en) 2019-01-29

Family

ID=58885224

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510814397.2A Active CN106749133B (en) 2015-11-23 2015-11-23 A method of preparing Ta Simeiqiong

Country Status (1)

Country Link
CN (1) CN106749133B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105949153A (en) * 2016-05-10 2016-09-21 浙江工业大学 Synthesis method of tasimelteon

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CN102675268A (en) * 2012-05-18 2012-09-19 济南志合医药科技有限公司 Method for preparing (1R,2R)-2-(2,3-dihydrobenzofuran-4-yl) cyclopropanemethylamine
CN103664697A (en) * 2012-09-07 2014-03-26 博瑞生物医药技术(苏州)有限公司 Chemical method used for preparing aromatic cyclopropanecarbonitrile and cyclopropylamine
CN104327022A (en) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 Preparation method of tasimelteon

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753709A (en) * 1995-06-07 1998-05-19 Bristol-Myers Squibb Company N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
CN102675268A (en) * 2012-05-18 2012-09-19 济南志合医药科技有限公司 Method for preparing (1R,2R)-2-(2,3-dihydrobenzofuran-4-yl) cyclopropanemethylamine
CN103664697A (en) * 2012-09-07 2014-03-26 博瑞生物医药技术(苏州)有限公司 Chemical method used for preparing aromatic cyclopropanecarbonitrile and cyclopropylamine
CN104327022A (en) * 2014-10-17 2015-02-04 苏州明锐医药科技有限公司 Preparation method of tasimelteon

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.SIVA PRASAD ET AL.,: "Development of Jacobsen Asymmetric Epoxidation and Sharpless Asymmetric Dihydroxylation Methods for the Large-Scale Preparation of a Chiral Dihydrobenzofuran Epoxide", 《ORGANIC PROCESS RESEARCH & DEVELOPMENT》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105949153A (en) * 2016-05-10 2016-09-21 浙江工业大学 Synthesis method of tasimelteon
CN105949153B (en) * 2016-05-10 2018-03-02 浙江工业大学 A kind of Ta Simeiqiong synthetic method

Also Published As

Publication number Publication date
CN106749133B (en) 2019-01-29

Similar Documents

Publication Publication Date Title
JP3527706B2 (en) Method for producing hydroxy-substituted γ-butyrolactone
CN110003151B (en) Process for the preparation of furanonic acids
CN108047076B (en) Preparation method of oseltamivir enantiomer
CN106365986A (en) Compounds and preparation methods thereof, and uses of compounds in synthesis of brivaracetam
CN105949153B (en) A kind of Ta Simeiqiong synthetic method
CN102229538B (en) Method for synthesizing dapoxetine
US8912345B2 (en) Method for preparing optically pure (−)-clausenamide compound
RU2702355C1 (en) Method of producing pyrimidinylcyclopentane compounds
CN106749133A (en) A kind of method for preparing Ta Simeiqiong
KR20160125115A (en) Preparation Method for 3-Hydroxytetrahydrofuran
KR100980379B1 (en) Process for the preparation of optically active 5-hydroxy-3-oxoheptanoate derivatives
CN108314688B (en) A kind of synthetic method of sitagliptin
CN108586272A (en) A kind of preparation method of 3- aminopropanols or 3- alanine derivatives
US9012457B2 (en) 2-carboxamide-4-piperazinyl-benzofuran derivative
KR20100118747A (en) Improved preparation method of sarpogrelate hydrochloride
CN105017158B (en) A kind of preparation method of cis Rosuvastatin calcium impurities
CN103204810B (en) A kind of tolvaptan intermediate and preparation method thereof
WO2010001379A1 (en) A process for preparing atovaquone and associate intermediates
CN104910033A (en) Method for preparing 5-aminolevulinic acid hydrochloride
CN104693071A (en) N-hydroxyl-N'-benzyl octanediamide preparation method
KR100982720B1 (en) Manufacturing Process of 2-Aminomalonamide as Intermediate for Producing 4-Carbamoyl-1-?-D-ribofuranosylimidazolium-5-olate
CN114213270B (en) Method for synthesizing atorvastatin calcium intermediate by using continuous flow micro-channel reactor
CN102358733B (en) 2-(1-oxy-1H-indene-3-radical) acetic acid compound and preparation method and application thereof
US20060241299A1 (en) Process for making spirolactone compounds
CN112724129A (en) Chiral purification method of compound B

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant